about
A novel mechanism for the biogenesis of outer membrane vesicles in Gram-negative bacteria.Crystal structure of human β2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndromeStructural flexibility of the N-terminal beta-barrel domain of 15-lipoxygenase-1 probed by small angle X-ray scattering. Functional consequences for activity regulation and membrane binding.Low density lipoproteins as circulating fast temperature sensorsBiophysical analysis of the interaction of the serum protein human β2GPI with bacterial lipopolysaccharide.Combined light and electron microscopy using diaminobenzidine photooxidation to monitor trafficking of lipids derived from lipoprotein particlesLiposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteriesInterleukin-10: an anti-inflammatory marker to target atherosclerotic lesions via PEGylated liposomes.Antibacterial activity of silver and zinc nanoparticles against Vibrio cholerae and enterotoxic Escherichia coliInterleukin 10-coated nanoparticle systems compared for molecular imaging of atherosclerotic lesions.Ultrasmall superparamagnetic iron oxide (USPIO)-based liposomes as magnetic resonance imaging probes.Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles.Thiomer-coated liposomes harbor permeation enhancing and efflux pump inhibitory properties.Molecular structure of low density lipoprotein: current status and future challenges.Tumor targeting and imaging with dual-peptide conjugated multifunctional liposomal nanoparticles.Nanoparticle-mediated treatment of pulmonary arterial hypertension.Use of X-ray scattering to aid the design and delivery of membrane-active drugs.Clinical potential of VIP by modified pharmaco-kinetics and delivery mechanisms.Antioxidant food supplements and obesity-related inflammation.Laboratory medicine for molecular imaging of atherosclerosis.Obesity-related dysregulation of the tryptophan-kynurenine metabolism: role of age and parameters of the metabolic syndrome.Softness of atherogenic lipoproteins: a comparison of very low density lipoprotein (VLDL) and low density lipoprotein (LDL) using elastic incoherent neutron scattering (EINS).Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging.Nanoparticles for intravascular applications: physicochemical characterization and cytotoxicity testing.A basis for vaccine development: Comparative characterization of Haemophilus influenzae outer membrane vesicles.Chemical coupling of thiolated chitosan to preformed liposomes improves mucoadhesive properties.Targeting properties of peptide-modified radiolabeled liposomal nanoparticles.Tracking morphologies at the nanoscale: self-assembly of an amphiphilic designer peptide into a double helix superstructure.Low-density lipoproteins investigated under high hydrostatic pressure by elastic incoherent neutron scattering.Impact of atomization technique on the stability and transport efficiency of nebulized liposomes harboring different surface characteristics.High hydrostatic pressure specifically affects molecular dynamics and shape of low-density lipoprotein particles.Liposomes coated with thiolated chitosan enhance oral peptide delivery to ratsPeptides at the Interface: Self-Assembly of Amphiphilic Designer Peptides and Their Membrane Interaction Propensity.Human low density lipoprotein: the mystery of core lipid packing.Long-term stability of sterically stabilized liposomes by freezing and freeze-drying: Effects of cryoprotectants on structure.Membrane binding of beta2-glycoprotein I can be described by a two-state reaction model: an atomic force microscopy and surface plasmon resonance study.Radiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: a comparison using different radiometals.Mechanism of the interaction of beta(2)-glycoprotein I with negatively charged phospholipid membranes.Structural characterisation of nucleoside loaded low density lipoprotein as a main criterion for the applicability as drug delivery system.Renewal of the air-water interface as a critical system parameter of protein stability: aggregation of the human growth hormone and its prevention by surface-active compounds.
P50
Q27334280-0909DF82-7180-4E71-B068-43809C0EF830Q27620388-A25FE2A6-C775-402C-BE79-BD41DAD4F0D4Q30163779-03F8A607-0772-4684-B274-956FBEC633EFQ30374137-F40E8C14-4D4B-48F8-B24D-FF8E6C783895Q33729006-DA290E7C-4DDD-441C-B1E5-B37FEBD1D279Q33864083-4098C735-AC3A-47FE-9620-8CA01509B95AQ33890202-69EBBE0D-6560-4B96-9C80-3402BAC40409Q34486748-9499464A-DD7E-459F-A234-4B767F2B0B6BQ34990310-FFBEB267-9CB1-461B-8EC8-3FAFE30BBD11Q35249558-26372CFF-58B3-45C8-84CC-0F432FA988ACQ35979160-BD8C5BC0-2C93-4899-9A26-D702BA929CF7Q36440766-C7EA9E6C-3DAC-4B92-81DF-58CA53D9C9A4Q36575250-7AFC3724-5E7D-459A-A2A2-CFFA27FD1EC7Q37271722-4A55E8B4-BEA8-419B-8053-AF0489DEC956Q37390746-AADBF625-1CEC-4AED-8E00-DB10F5C7CFDBQ37997222-8FE5E523-7AE9-4771-8E51-4B5C689792E4Q38015717-955FBF96-CC7E-4DC3-87E4-844C3AFC0D70Q38055216-236B8C77-8770-42C2-BEF9-358057BA31F3Q38093312-CF6F7D0C-7988-4D11-B950-24ED975541B8Q38227256-5DF560C9-9258-4D38-A92E-BA04EAF679D1Q38315972-812B87AE-45C3-4D2B-8543-5737AEBD008FQ38443923-C6375CFA-4143-47AF-83EA-32AE53A775ADQ38548184-C702CBEE-4808-4002-9A07-69574A2AEBD6Q38891729-72DFD518-C0F5-45CB-9CE0-B99D609BD28CQ39057383-E6D45964-80DF-4120-8015-0B38E2CDA385Q39334856-05F2BFB5-6429-4C52-8DFF-45CABA4591B2Q39529811-AD90E2A5-2902-4217-AC70-4D574B926F15Q40625022-328D416D-1236-40C3-A25A-A5FEE03F13BAQ41577799-712BD06C-32DF-481D-874D-FA6B2F9C6000Q41743148-78CFDF0B-C9F7-4341-9C4A-91EAE9C92D15Q41779566-BC547437-8DC2-45D4-97CA-5F2B430BDAAAQ41913979-9321D381-0879-40E2-A3D9-DF8E6EFD84E0Q42368073-CF69D9F4-83B0-416B-B0E3-5CB6886F9802Q42575536-F7973D0D-4F92-40DE-9D0C-3B4E5E431DA3Q42923743-0796F6C6-92AA-42E5-9A37-6541059191A1Q42928356-15DF7826-5F3A-4DA7-BCFE-DEC55E844D68Q43253511-F155DA37-691D-4062-A2CC-71E3EC9174F2Q43803156-F30AE4AB-4E89-42F0-A8B0-DB94212E5A29Q44401054-AB66123C-8AB0-4182-B55F-5CE0B179F08FQ44776180-C687E91E-1939-4203-B188-DAF102E5A6B0
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ruth Prassl
@ast
Ruth Prassl
@en
Ruth Prassl
@es
Ruth Prassl
@nl
Ruth Prassl
@sl
type
label
Ruth Prassl
@ast
Ruth Prassl
@en
Ruth Prassl
@es
Ruth Prassl
@nl
Ruth Prassl
@sl
prefLabel
Ruth Prassl
@ast
Ruth Prassl
@en
Ruth Prassl
@es
Ruth Prassl
@nl
Ruth Prassl
@sl
P108
P106
P1153
6602687129
P21
P31
P496
0000-0002-1010-9494